Celanese CORP

Market Movers (8-K)

See all →
NYSE
Celanese Corporation announced robust second quarter 2026 financial results, driven by strong commercial performance in both its Engineered Materials and Acetyl Chain segments, alongside strategic operational improvements.
NYSE
Celanese Corporation announced robust second quarter 2026 financial results, showcasing an 18% sequential increase in net sales driven by significant price and volume gains.
NYSE
Celanese US Holdings LLC has issued a notice to redeem all outstanding 4.777% Senior Notes due July 19, 2026, with the redemption expected on June 25, 2026.
NYSE
Celanese Corporation announced its first quarter 2026 financial results, highlighting adjusted EPS of $0.85 and a positive free cash flow of $3 million, while detailing strategic actions to enhance long-term value creation.
NYSE
Celanese Corporation announced first quarter 2026 results, with net sales up 6% sequentially, and raised its full-year free cash flow outlook.
NYSE
Celanese Corporation has expanded its Board of Directors to 10 members with the appointment of industry veteran Anne P. Noonan.

Quarterly Earnings (10-Q)

See all →
NYSE
Celanese Corporation's Q2 2026 results show a significant increase in operating profit driven by strategic pricing actions, despite facing lower sales volumes and increased operational costs.
NYSE
Celanese Corporation reports a significant net loss in Q3 2025, primarily due to substantial goodwill and intangible asset impairments, alongside declining sales volumes and pricing.
Delay expected
Worse than expected
Capital raise
NYSE
Celanese Corporation reports a decline in net sales and operating profit for Q2 and H1 2025 due to weak global demand and competitive pricing, partially offset by significant tax benefits and cost savings.
Worse than expected
Capital raise
Delay expected
NYSE
Celanese US Holdings issued \$2.55 billion in senior notes and completed tender offers for existing notes, while facing demand challenges in key end-markets.
Worse than expected
NYSE
Celanese Corporation's Q3 2024 results reflect a decrease in net sales and operating profit, influenced by lower pricing and demand, alongside strategic actions including a dividend reduction and facility closures.
Worse than expected
Delay expected
NYSE
Celanese Corporation's second quarter 2024 results show a decrease in net sales and operating profit compared to the same period last year, influenced by pricing pressures and lower volumes in some segments.
Worse than expected
Delay expected

Annual Reports (10-K)

NYSE
Celanese Corporation reported a net loss of $1.151 billion for 2025, driven by lower sales volumes, pricing pressures, and significant goodwill and intangible asset impairment losses, despite deleveraging efforts.
Delay expected
Worse than expected
Capital raise
NYSE
Celanese Corporation's 2024 10-K filing reveals a year of mixed performance, marked by a goodwill impairment, strategic realignments, and a focus on deleveraging.
Worse than expected
Delay expected
NYSE
Celanese Corporation's 10-K filing outlines its registered securities, capital structure, governance policies, and debt obligations.

Insider Trading (Form 4)

See all →
NYSE
Chuck Kyrish, SVP & CFO of Celanese Corp, purchased 2,300 shares of common stock on August 14, 2026.
NYSE
Ashley B Duffie, SVP & GC of Celanese Corp, purchased 600 shares of common stock on August 11, 2026 for $45.60 per share.
NYSE
Mark Christopher Murray, SVP - Acetyls of Celanese Corp, purchased 2,153 shares of common stock on August 11, 2026 for $45.52 per share.
NYSE
Deborah J. Kissire, a Director of Celanese Corp, received 6 shares of common stock on August 10, 2026.
NYSE
Kim K.W. Rucker, a Director of Celanese Corp, received 9 shares of common stock on August 10, 2026.
NYSE
Edward G Galante, a Director of Celanese Corp, reported multiple transactions in common stock on August 10, 2026.

Proxy Statements (Def-14A)

See all →
NYSE
Celanese Corporation announces its 2026 Annual Meeting of Shareholders, outlining director nominees, executive compensation, and corporate governance practices.
Worse than expected
NYSE
Celanese Corporation amends its proxy statement to correct an omission on the proxy card and notice of internet availability for its upcoming annual shareholder meeting.
NYSE
Celanese Corporation has filed a definitive proxy statement with the SEC.
NYSE
Celanese Corporation is seeking shareholder approval to eliminate supermajority voting requirements in its charter, aiming for more agile corporate governance.
NYSE
Celanese Corporation has filed a definitive proxy statement with the SEC.
NYSE
Celanese Corporation's proxy statement outlines director nominees, executive compensation details, and proposals for shareholder voting at the upcoming annual meeting.
Worse than expected

Schedule 13G - Passive Investments

See all →
NYSE
Norges Bank has reported a beneficial ownership of 8.7955% in Celanese Corp's common stock as of June 30, 2026, holding 9,645,359 shares.
NYSE
Norges Bank has reported beneficial ownership of 6,924,205 shares, representing 6.1866% of Celanese Corp's common stock as of March 31, 2026.
NYSE
Vanguard Capital Management has reported beneficial ownership of 5.15% of Celanese Corp's common stock as of March 31, 2026.
NYSE
Vanguard Portfolio Management has reported a beneficial ownership of 5.65% in Celanese Corp's common stock as of March 31, 2026.
NYSE
The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in Celanese Corp following an internal realignment.
NYSE
Capital Research Global Investors has reported a 5.1% beneficial ownership stake in Celanese Corp. common stock as of December 31, 2025.